Blood

Non-Hodgkin lymphoma

ORPHA:547 ↗

Search all Non-Hodgkin lymphoma trialsAlert me when a trial opens

studies recruiting now

checking live

studies registered in total

checking live

countries with a recruiting site

checking live

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Non-Hodgkin lymphoma study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:547 ↗

A group of conditions, not a single diagnosis

Orphanet classifies “Non-Hodgkin lymphoma” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

16 approved treatments and 190 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: CopanlisibApproved: Methotrexate (Ebetrex)Approved: Pixantrone Dimaleate (Pixuvri)Approved: Carmustine (Bicnu)Approved: FebarbamateApproved: Tositumomab (Tositumomab component of bexxar)Approved: Bendamustine Hydrochloride (Belrapzo)Approved: Rituximab (Blitzima)Approved: Doxorubicin Hydrochloride (Adriamycin)Approved: Plerixafor (Mozobil)Approved: Idelalisib (Zydelig)Approved: Methotrexate Sodium (Abitrexate)Approved: Brentuximab Vedotin (Adcetris)Approved: Melphalan (Alkeran)Approved: TrofosfamideApproved: Pirtobrutinib (Jaypirca)

Phase 3Doxorubicin (Adriblastina)

Phase 3Cytarabine (Alexan)

Phase 3Pixantrone

Phase 3Enzastaurin (Kinenza)

Phase 3Ofatumumab (Arzerra)

Phase 3Tocilizumab (Actemra roactemra)

Phase 3Cisplatin (Cisplatin)

Phase 3Ibrutinib (Imbruvica)

+ 182 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).